NCT07540065Not yet recruiting
AI-Assisted Workflow for Occult Atrial Fibrillation Detection After Ischemic Stroke: A Prospective Randomized Trial
Source: ClinicalTrials.gov · Last updated 20 Apr 2026
Brief summary (registry, in English)
We hypothesize that an AI-guided AF risk stratification approach, particularly when combined with intensified rhythm monitoring using wearable devices and extended ECG patches, will significantly increase AF detection rates compared with standard care. By enabling earlier identification of patients who may benefit from anticoagulation therapy, this strategy has the potential to improve clinical outcomes while minimizing unnecessary exposure to anticoagulant-related bleeding risks. Ultimately, this trial seeks to provide robust clinical evidence supporting the integration of AI-assisted ECG analysis into routine post-stroke care, advancing precision medicine and optimizing resource allocation for patients with ischemic stroke.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 7 Jan 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT07540065
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 1 Oct 2026 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous diagnosis of atrial fibrillation or flutter;
Other illness
- Pre-existing cardiac implantable electronic device (IVD);
- Known contraindications to non-vitamin K antagonist oral anticoagulants due to comorbidities, including but not limited to end-stage renal disease, severe mitral stenosis due to rheumatic heart disease, or metallic heart valves;
Other
- Diagnosis of atrial fibrillation during hospitalization;
- Expected inability to attend regular outpatient follow-ups after discharge, or to undergo multiple 14-day ECG recordings;
- Requires long-term anticoagulant use for other reasons, including but not limited to chronic pulmonary embolism;
- Unwilling to sign a participant consent form.
Who the study is looking for
- 18 years or older who are acutely hospitalized due to ischemic stroke;
- A 12-lead electrocardiogram upon admission showing sinus rhythm;
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospita Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.